As reported for human AD brains, brain tissue from APP/tau mice showed increased 12-HETE levels at the early symptomatic phase and decreased levels of both pPEs and SMs with medium chain fatty acids at the late symptomatic phase compared with control mice. This evidence concerns the gene APP and Alzheimer disease.